Virology & Mycology
Open Access

Influenza Virus: The Microscopic Ability to Mutate Rapidly in Human Immune System

Caramine Seline^{* *}Correspondence: Caramine Seline, Department of Medicine, University of Houston, Houston, Texas, USA, Email:

Author info »

Description

Influenza, often referred to as the flu, is a viral infection that has plagued humanity for centuries. It is a highly contagious respiratory illness caused by the influenza virus, which affects millions of people worldwide every year. Despite its widespread prevalence, influenza remains a source of concern due to its ability to mutate rapidly and cause seasonal epidemics and occasional pandemics. In this article, we will delve into the influenza virus, its structure, transmission, symptoms, prevention, and the ongoing efforts to combat this microscopic menace.

The influenza virus

The influenza virus belongs to the Orthomyxoviridae family and is classified into three main types: influenza A, influenza B, and influenza C. Influenza A is the most common and versatile type, capable of infecting various species, including birds, pigs, and humans. This versatility is what makes it a potential source of pandemics. Influenza B primarily affects humans, while influenza C causes mild respiratory symptoms.

The influenza virus is enveloped and contains a single-stranded RNA genome. Its outer surface is studded with two crucial proteins, Hemagglutinin (HA) and Neuraminidase (NA), which determine its subtype and play a significant role in the infection process. These proteins are the targets for the development of antiviral medications and vaccines.

Transmission

Influenza spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. It can also spread by touching surfaces contaminated with the virus and then touching the face. The virus can be contagious even before symptoms appear, making it challenging to control its transmission.

Symptoms

In most cases, influenza is a self-limiting illness, and symptoms improve within a week or two. However, it can lead to severe complications, especially in high-risk individuals, such as the elderly, young children, pregnant women, and people with underlying health conditions. These complications may include pneumonia, bronchitis, sinus infections, and exacerbation of chronic diseases.

Prevention

Preventing influenza is crucial to reduce its impact on public health. The most effective preventive measure is vaccination. Seasonal influenza vaccines are formulated each year to protect against the most prevalent strains. Vaccination not only reduces the risk of infection but also lessens the severity of the disease if one does contract the virus.

Besides vaccination, several other preventive measures can help reduce the spread of influenza.

Hand hygiene: Frequent handwashing with soap and water or using hand sanitizer can prevent the virus from spreading through contaminated surfaces [1].

Respiratory etiquette: Covering your mouth and nose when coughing or sneezing can prevent the release of respiratory droplets.

Avoid close contact: Stay away from individuals who are sick, and if you are sick, try to limit contact with others.

Disinfection: Regularly clean and disinfect frequently touched surfaces and objects.

Mask-wearing: During flu outbreaks, wearing a mask can help reduce the spread of the virus [2].

Treatment

Antiviral medications can be used to treat influenza, but they are most effective when administered early in the course of the illness. These drugs work by inhibiting the functions of the HA and NA proteins on the virus's surface. Common antiviral medications include oseltamivir (Tamiflu) and zanamivir (Relenza) [3].

The fight against influenza

In the ongoing battle against influenza, scientists and healthcare professionals are continually researching and developing new strategies to prevent and control the virus. This includes the development of more effective vaccines, improving surveillance and monitoring of influenza strains, and studying the genetic variations of the virus to predict its behavior [4].

Conclusion

Influenza is a persistent threat to public health, causing seasonal epidemics and the occasional pandemic with the potential for devastating consequences. Understanding the influenza virus, its transmission, symptoms, prevention, and treatment is essential for individuals and communities to protect themselves from this microscopic menace. Through vaccination, hygiene practices, and ongoing research efforts, we can work together to mitigate the impact of influenza and reduce its toll on society.

References

1. Adams CM, Reitz J, De Brabander JK, Feramisco JD, Li L, Brown MS, et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem. 2004;279(50):52772-52780.

   [CrossRef] [Google Scholar] [PubMed]

2. Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology. 2017;510:234-241.

   [CrossRef] [Google Scholar] [PubMed]

3. Blanc M, Hsieh WY, Robertson KA, Kropp KA, Forster T, Shui G, et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity. 2013;38(1):106-118.

   [CrossRef] [Google Scholar] [PubMed]

4. Brown MS, Goldstein JL. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980 ;21(5):505-517.

   [CrossRef] [Google Scholar] [PubMed]